224 related articles for article (PubMed ID: 23657302)
21. Hepatitis C virus coinfection independently increases the risk of cardiovascular disease in HIV-positive patients.
Fernández-Montero JV; Barreiro P; de Mendoza C; Labarga P; Soriano V
J Viral Hepat; 2016 Jan; 23(1):47-52. PubMed ID: 26390144
[TBL] [Abstract][Full Text] [Related]
22. Natural history of hepatitis C virus infection in HIV-infected individuals and the impact of HIV in the era of highly active antiretroviral therapy: a meta-analysis.
Thein HH; Yi Q; Dore GJ; Krahn MD
AIDS; 2008 Oct; 22(15):1979-91. PubMed ID: 18784461
[TBL] [Abstract][Full Text] [Related]
23. Factors affecting liver fibrosis in human immunodeficiency virus-and hepatitis C virus-coinfected patients: impact of protease inhibitor therapy.
Benhamou Y; Di Martino V; Bochet M; Colombet G; Thibault V; Liou A; Katlama C; Poynard T;
Hepatology; 2001 Aug; 34(2):283-7. PubMed ID: 11481613
[TBL] [Abstract][Full Text] [Related]
24. Liver fibrosis on account of chronic hepatitis C is more severe in HIV-positive than HIV-negative patients despite antiretroviral therapy.
de Lédinghen V; Barreiro P; Foucher J; Labarga P; Castéra L; Vispo ME; Bernard PH; Martin-Carbonero L; Neau D; García-Gascó P; Merrouche W; Soriano V
J Viral Hepat; 2008 Jun; 15(6):427-33. PubMed ID: 18221303
[TBL] [Abstract][Full Text] [Related]
25. Structural Bone Deficits in HIV/HCV-Coinfected, HCV-Monoinfected, and HIV-Monoinfected Women.
Lo Re V; Lynn K; Stumm ER; Long J; Nezamzadeh MS; Baker JF; Hoofnagle AN; Kapalko AJ; Mounzer K; Zemel BS; Tebas P; Kostman JR; Leonard MB
J Infect Dis; 2015 Sep; 212(6):924-33. PubMed ID: 25754980
[TBL] [Abstract][Full Text] [Related]
26. Phylogenetic Diversity in Core Region of Hepatitis C Virus Genotype 1a as a Factor Associated with Fibrosis Severity in HIV-1-Coinfected Patients.
Parra M; Laufer N; Manrique JM; Jones LR; Quarleri J
Biomed Res Int; 2017; 2017():1728456. PubMed ID: 29259976
[TBL] [Abstract][Full Text] [Related]
27. Impact of human immunodeficiency virus (HIV) infection on the progression of liver fibrosis in hepatitis C virus infected patients.
Mohsen AH; Easterbrook PJ; Taylor C; Portmann B; Kulasegaram R; Murad S; Wiselka M; Norris S
Gut; 2003 Jul; 52(7):1035-40. PubMed ID: 12801963
[TBL] [Abstract][Full Text] [Related]
28. Incidence of hepatocellular carcinoma in patients with chronic liver disease due to hepatitis B or C and coinfected with the human immunodeficiency virus: A retrospective cohort study.
Marcon PDS; Tovo CV; Kliemann DA; Fisch P; de Mattos AA
World J Gastroenterol; 2018 Feb; 24(5):613-622. PubMed ID: 29434450
[TBL] [Abstract][Full Text] [Related]
29. The absence of the human platelet antigen polymorphism effect on fibrosis progression in human immunodeficiency virus-1/hepatitis C virus coinfected patients.
Picelli N; Tanikawa AA; Grotto RM; Silva GF; Barbosa AN; Ferrasi AC; Silveira LV; Pardini MI
Rev Soc Bras Med Trop; 2015; 48(4):406-9. PubMed ID: 26312929
[TBL] [Abstract][Full Text] [Related]
30. Liver fibrosis progression and clinical outcomes are intertwined: role of CD4+ T-cell count and NRTI exposure from a large cohort of HIV/HCV-coinfected patients with detectable HCV-RNA: A MASTER cohort study.
Focà E; Fabbiani M; Prosperi M; Quiros Roldan E; Castelli F; Maggiolo F; Di Filippo E; Di Giambenedetto S; Gagliardini R; Saracino A; Di Pietro M; Gori A; Sighinolfi L; Pan A; Postorino MC; Torti C;
Medicine (Baltimore); 2016 Jul; 95(29):e4091. PubMed ID: 27442636
[TBL] [Abstract][Full Text] [Related]
31. Marijuana Use Is Not Associated With Progression to Advanced Liver Fibrosis in HIV/Hepatitis C Virus-coinfected Women.
Kelly EM; Dodge JL; Sarkar M; French AL; Tien PC; Glesby MJ; Golub ET; Augenbraun M; Plankey M; Peters MG
Clin Infect Dis; 2016 Aug; 63(4):512-8. PubMed ID: 27225241
[TBL] [Abstract][Full Text] [Related]
32. HIV-HCV co-infected patients with low CD4+ cell nadirs are at risk for faster fibrosis progression and portal hypertension.
Reiberger T; Ferlitsch A; Sieghart W; Kreil A; Breitenecker F; Rieger A; Schmied B; Gangl A; Peck-Radosavljevic M
J Viral Hepat; 2010 Jun; 17(6):400-9. PubMed ID: 19780945
[TBL] [Abstract][Full Text] [Related]
33. [Evaluation of APRI score in liver disease following the introduction of antiretroviral therapy in HIV and HCV coinfected versus HIV monoinfected patients].
Antonello VS; Tovo CV; Kliemann DA; Santos BR; Zaltron VF
Rev Soc Bras Med Trop; 2010; 43(6):678-81. PubMed ID: 21181022
[TBL] [Abstract][Full Text] [Related]
34. Incidence of and factors associated with hepatocellular carcinoma among hepatitis C virus and human immunodeficiency virus coinfected patients with decompensated cirrhosis.
García-García JA; Romero-Gómez M; Girón-González JA; Rivera-Irigoin R; Torre-Cisneros J; Montero JL; González-Serrano M; Andrade RJ; Aguilar-Guisado M; Grilo I; Martín-Vivaldi J; Salmerón J; Caballero-Granado FJ; Macías J; Vergara-López S; Pineda JA; ;
AIDS Res Hum Retroviruses; 2006 Dec; 22(12):1236-41. PubMed ID: 17209765
[TBL] [Abstract][Full Text] [Related]
35. Fibrosis is worse in HIV-HCV patients with low-level immunodepression referred for HCV treatment than in HCV-matched patients.
Rullier A; Trimoulet P; Neau D; Bernard PH; Foucher J; Lacoste D; Winnock M; Urbaniak R; Ballardini G; Balabaud C; Bioulac-Sage P; Le Bail B
Hum Pathol; 2004 Sep; 35(9):1088-94. PubMed ID: 15343510
[TBL] [Abstract][Full Text] [Related]
36. Liver biopsy findings for HIV-infected patients with chronic hepatitis C and persistently normal levels of alanine aminotransferase.
Sánchez-Conde M; Berenguer J; Miralles P; Alvarez F; Carlos Lopez J; Cosin J; Pilar C; Ramirez M; Gutierrez I; Alvarez E
Clin Infect Dis; 2006 Sep; 43(5):640-4. PubMed ID: 16886160
[TBL] [Abstract][Full Text] [Related]
37. Association of torque teno virus (TTV) and torque teno mini virus (TTMV) with liver disease among patients coinfected with human immunodeficiency virus and hepatitis C virus.
García-Álvarez M; Berenguer J; Alvarez E; Guzmán-Fulgencio M; Cosín J; Miralles P; Catalán P; López JC; Rodríguez JM; Micheloud D; Muñoz-Fernández MA; Resino S
Eur J Clin Microbiol Infect Dis; 2013 Feb; 32(2):289-97. PubMed ID: 22983402
[TBL] [Abstract][Full Text] [Related]
38. Moderate Alcohol Use Is Not Associated With Fibrosis Progression in Human Immunodeficiency Virus/Hepatitis C Virus-Coinfected Women: A Prospective Cohort Study.
Kelly EM; Dodge JL; Bacchetti P; Sarkar M; French AL; Tien PC; Glesby MJ; Golub ET; Augenbraun M; Plankey M; Peters MG
Clin Infect Dis; 2017 Nov; 65(12):2050-2056. PubMed ID: 29020382
[TBL] [Abstract][Full Text] [Related]
39. Fibrosis Progression in Paired Liver Biopsies from HIV/HCV-Coinfected Patients without Prior Treatment of Hepatitis C.
Leite AG; Duarte MI; Mendes-Correa MC
J Int Assoc Provid AIDS Care; 2015; 14(5):463-8. PubMed ID: 26056147
[TBL] [Abstract][Full Text] [Related]
40. A new 3p25 locus is associated with liver fibrosis progression in human immunodeficiency virus/hepatitis C virus-coinfected patients.
Ulveling D; Le Clerc S; Cobat A; Labib T; Noirel J; Laville V; Coulonges C; Carpentier W; Nalpas B; Heim MH; Poynard T; Cerny A; Pol S; Bochud PY; Dabis F; Theodorou I; Lévy Y; Salmon D; Abel L; Dominguez S; Zagury JF; ; ;
Hepatology; 2016 Nov; 64(5):1462-1472. PubMed ID: 27339598
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
